An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia  A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study  J. Gonçalves-Pereira,
The effect of age on the systemic inflammatory response in patients with community- acquired pneumonia  L.A. van Vught, H. Endeman, S.C. Meijvis, A.H.
L. Boyanova  Clinical Microbiology and Infection 
C.N. van Ettekoven, D. van de Beek, M.C. Brouwer 
Gut bacterial microbiota and obesity
Herpes zoster in non-hospitalized children
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M
J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
B. Beović, S. Kreft, J. Osredkar, D. Keše, B. Bonač-Tuma 
R. Cantón  Clinical Microbiology and Infection 
A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia  M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study  J. Gonçalves-Pereira,
Vector control: a cornerstone in the malaria elimination campaign
Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia  F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer,
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Community-acquired pneumonia: the evolving challenge
Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands 
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Levofloxacin in the treatment of ventilator-associated pneumonia
J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study  K.O. Gradel, R.W. Thomsen, S.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Molecular identification of Acinetobacter sp
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Statin use and clinical outcomes among pneumonia patients
G. De Angelis, A. Murthy, J. Beyersmann, S. Harbarth 
Clinical Microbiology and Infection
Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis  Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,
Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia  Bo Söderquist, Dan Danielsson,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia  U. Hohenthal, S. Hurme, H. Helenius,
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Community-acquired acute bacterial meningitis in the elderly in Turkey
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study) 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia  A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford, A. Singanayagam, A.T. Hill  Clinical Microbiology and Infection  Volume 19, Issue 12, Pages 1174-1180 (December 2013) DOI: 10.1111/1469-0691.12173 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Discriminatory ability of stability criteria according to day of admission. Where indices are similar, overlapping points have been offset. Note that there are no data for ATS criteria on day 0 as these criteria cannot be met on day 0. C-reactive protein data on day 0 are for those patients in whom CRP was not elevated (<10 mg/L) on admission. Clinical Microbiology and Infection 2013 19, 1174-1180DOI: (10.1111/1469-0691.12173) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions